MigVax logo

MigVax jobs and careers

About MigVax

MigVax is a startup developing Migvax-101, a novel oral subunit COVID-19 vaccine that has demonstrated effectivity in pre-clinical tests as a booster for previously vaccinated persons

Founded
2020
Employees
11 to 50
Total funding
$16.3M

Leadership

The top of MigVax's org chart, with how many people report into each leader.

DZPhoto of David Zigdon

David Zigdon

President